[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "GLS-5310", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "GLS-5310", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "GLS-5310", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "GLS-5310", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "0.6mg of GLS-5310 will be intradermally administered on Day 0 and Week 8", "treatment_id": 546, "treatment_name": "Gls-5310", "treatment_type": "Dna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "1.2mg of GLS-5310 will be intradermally administered on Day 0 and Week 8.", "treatment_id": 546, "treatment_name": "Gls-5310", "treatment_type": "Dna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "1.2mg of GLS-5310 will be intradermally administered on Day 0 and Week 12.", "treatment_id": 546, "treatment_name": "Gls-5310", "treatment_type": "Dna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]